Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.133
+0.003 (0.22%)
May 9, 2025, 4:00 PM - Market closed
Evogene Market Cap
Evogene has a market cap or net worth of $7.48 million as of May 12, 2025. Its market cap has decreased by -79.92% in one year.
Market Cap
7.48M
Enterprise Value
11.06M
1-Year Change
-79.92%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $7.48M, a decrease of -73.30%. That is a compound annual growth rate of -7.24%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |